YMYiannis Mavrommatis

Yiannis Mavrommatis

*This is an algorithmically generated author record based on publicly available information.

Yiannis Mavrommatis has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interaction of melatonin receptor 1B (MTNR1B) genotype and type of breakfast (protein-enriched v carbohydrate-rich) on postprandial glucose response: a randomised crossover trial.

    by Alexandra King, Yiannis Mavrommatis, Jonathan Nixon, Angeliki Kapellou, Jonathan Craven, Catherine Graham, Leta Pilic

    Background The risk allele (G) of MTNR1B rs10830963 has been associated with impaired glucose tolerance, increased fasting glucose and type 2 diabetes (T2D). Late evening eating, when endogenous melatonin levels are elevated, is associated with impaired glucose control in MTNR1B risk carriers. Endogenous melatonin levels remain elevated into the morning so may influence glucose response to breakfast. Objective To investigate the interaction of MTNR1B genotype and type of breakfast on postprandial glucose response. Methods Following an overnight fast, participants consumed either a standard carbohydrate-rich or protein-enriched porridge breakfast. Post-prandial glucose levels were recorded for two hours using a continuous glucose monitor (CGM). One week later, participants repeated the protocol consuming the alternate breakfast. A two-way mixed ANOVA determined the effect of breakfast and genotype on post-prandial glucose levels. Results Fifty-four adults completed the study. Fasting glucose was significantly higher (p = 0.008) in GG (5.53 ± 0.43 mmol/L) compared to CC or CG participants (5.02 ± 0.42 and 5.19 ± 0.52 mmol/L). Post-prandial iAUC was significantly greater following the carbohydrate-rich breakfast compared to the protein-enriched breakfast (p < 0.001). Following the carbohydrate-rich breakfast iAUC was significantly greater in GG participants compared to CC (p = 0.026) and CG participants (p = 0.029). There was no significant difference between genotype groups following the protein-enriched breakfast (p > 0.05). Conclusion The study findings demonstrate, in a relatively young and healthy population, MTNR1B genotype significantly affects markers associated with T2D risk. Personalised genotype-based advice to adjust timing and composition of meals consumed when endogenous melatonin levels are increased may reduce subsequent T2D risk.

  • Loss aversion and genetic variants influence food choice: Implications for healthier dietary decisions

    by Catherine Anna-Marie Graham, Emily Swift, Sarah Kennedy, Shincy Sivadasan, Joycey Manju Varkey, Leta Pilic, Alexandra King, Yiannis Mavrommatis

    Loss aversion, the cognitive bias favouring avoiding losses over equivalent gains, has been linked to dietary choices. Independently, genetic variation affecting dopaminergic function has been associated with loss aversion. This study examined the influence of loss aversion and genetic variation on food choices based on perceived healthiness. This is a randomised cross-over study. Participants completed two food choice tasks, scale-up (adding toppings) and scale-down (removing/keeping toppings). Participants rated the perceived healthiness of each food item. Loss aversion was objectively assessed using a small-stake gambling task, classifying individuals as highly (LA H ) or lowly (LA L ) loss averse. Buccal samples were collected for genetic analysis, and all data were obtained via Joint Information Systems Committee (JISC) Online Surveys. Both LA H and LA L participants kept more toppings than they added. LA H participants kept more healthy and unhealthy toppings, whereas LA L kept only more healthy toppings than they added. Genetic variation had an opposing effect in the LA H and LA L groups, leading to the differences in the addition of total toppings and unhealthy toppings (scale up) and removal of unhealthy toppings (scale down). Therefore, high loss aversion combined with genetic predispositions to reduced dopamine activity may promote greater food retention, irrespective of perceived healthiness. In contrast, genetic variants and lower loss aversion are associated with more selective, health-oriented choices. Findings warrant further investigation in larger cohorts to elucidate underlying mechanisms and inform personalised dietary interventions.

  • Open Access

    Associations of CD36 rs1761667 with Fat and Umami Food Perception, Diet Quality, and BMI in Two European Studies

    by Francesco Piluso, Catherine Anne-Marie Graham, Harry Stevens, Silvia Camarda, Alexandra King, Leta Pilic, Yiannis Mavrommatis, Paolo Gasparini, Maria Pina Concas

    Background/Objectives: Fat, a newly researched taste, has been associated with the cluster of differentiation 36 (CD36) gene, which codes for the CD36 receptor protein. The rs1761667 variant has been associated with fat taste sensitivity. Furthermore, umami is a well-established taste with known receptors. The combination of these tastes is common in food; nevertheless, they have not been extensively investigated together. This study aimed to assess whether CD36 rs1761667 is associated with food liking and the perception of fat and umami foods. Methods: Two studies were conducted: A field study on 235 individuals from Italy and a laboratory study on 49 individuals from the UK. Data includes demographics, anthropometrics, a food liking questionnaire or a fat and umami food flavour test, dietary intake assessment, and rs1761667 genotyping. Results: Study 1: The rs1761667 A-allele was associated with a reduced liking for fatty and umami foods in individuals with BMI ≥ 25. Study 2: The rs1761667 A-allele was associated with an increased intensity of the umami food samples, and a significant positive association of rs1761667 with BMI and DQS was found. Conclusions: This study is the first to address the potential links between rs1761667, fat, umami, diet, and BMI. Further research is required to confirm these findings.


  • Open Access

    TAS1R2 rs35874116 Associations with Taste, Diet, and Health in an Italian Population

    by Harry Stevens, Catherine Anna-Marie Graham, Maria Pina Concas, Francesco Piluso, Yiannis Mavrommatis, Alexandra King, Leta Pilic, Paolo Gasparini

    Background/Objectives: The TAS1R2 SNP rs35874116 has previously been associated with sweet taste, diet, and health status, although never comprehensively in a single study. Also, associations between TAS1R2 and sweet taste might be body mass index (BMI)-dependent. Therefore, this study aimed to conduct a comprehensive investigation of rs35874116 and sweet taste intensity and liking, food liking, and diet and health status whilst considering BMI. Methods: Five-hundred and fifty-four participants were recruited. Linear regression models were used to explore rs35874116 associations with sweet taste intensity and liking, food liking, and diet and health status. A secondary analysis stratified participants by BMI 2. Results: The rs35874116 wildtype was associated with increased sweet taste intensity (p = 0.0345, B 1.29, SE 0.61) and liking (p = 0.021, B 0.25, SE 0.11). However, these associations only remained in BMI ≥25 individuals (intensity: p = 0.037, B 1.29, SE 0.61, liking: p = 0.008, B 0.46, SE 0.17). It was also associated with decreased diet quality (p = 0.03, B −0.27, SE 0.13) and reduced free sugar consumption but increased saturated fat consumption in BMI ≥25 individuals (free sugars: p = 0.0416, B −0.8, SE 0.38, saturated fat: p = 0.031, B 1.38, SE 0.62). There was no association with the mean liking score for sweet foods, although there were some associations with individual foods, which require further investigation. There were no associations with health status. Conclusions: This study revealed an association between the rs35874116 wildtype and an increased intensity and liking of the sweet taste and a corresponding worse overall dietary quality. This study adds to previous evidence regarding how associations between TAS1R2 and sweet taste are BMI-dependent.


  • Open Access

    A randomised controlled trial to determine the effect of genotype‐based personalised diet and physical activity advice for FTO genotype (rs9939609) delivered via email on healthy eating motivation in young adults

    by Alexandra King, Mark Glaister, Kate Lawrence, Jonathan Nixon, Leta Pilic, Yiannis Mavrommatis

    The prevalence of obesity continues to rise, and public health dietary recommendations are not being adhered to. The transition to higher education is a period of risk for weight gain in young adults and has been demonstrated as a good time to initiate behaviour change. A genotype‐based personalised approach to dietary recommendations may motivate young adults to maintain or adopt positive dietary behaviours. The aim of the present study was to determine the efficacy of genotype‐based personalised dietary and physical activity advice on healthy eating motivation in young adults. Participants were young adults (n = 153), aged 18–25 years. Baseline measures (participant characteristics, height, weight, body mass index [BMI], body fat percentage [BF%], healthy eating motivation and physical activity) were collected. Participants were genotyped for a SNP in the FTO gene (rs99396090) and randomly allocated (stratified for genotype) to three different groups (1. Genotype‐based personalised advice: dietary and physical activity advice based on genotype, BMI and reported physical activity; 2. Non‐genotype‐based personalised advice: dietary and physical activity advice based on BMI and reported physical activity; 3. Control: no advice). A week after receipt of advice delivered via email, participants completed the healthy eating motivation questionnaire for a second time. Genotype‐based personalised dietary advice did not affect healthy eating motivation: when participants were analysed across the whole group (p = 0.417), when analysed according to those informed of a risk or non‐risk‐associated genotype (p = 0.287), or when analysed according to those with a BMI (>25 kg/m2; p = 0.336) or BF% (male >18%, female >31%; p = 0.387) outside the healthy range. There was also no significant difference in healthy eating motivation at 1‐week in the control or non‐genotype‐based advice groups. Genotype‐based personalised advice for the prevention of obesity did not affect healthy eating motivation in this group of healthy, young adults.


  • Open Access

    Factors influencing the intention of young adults to adopt genotype-based personalised advice on diet and physical activity according to perceived weight status

    by Alexandra King, Mark Glaister, Kate Lawrence, Leta Pilic, Yiannis Mavrommatis

    Genotype-based dietary and physical activity advice can be delivered to young adults before unhealthy lifestyle behaviours or metabolic and physiological conditions have developed. The aim of the present study was to investigate the factors that influence the intention to adopt genotype-based personalised advice on diet and physical activity in young adults who perceive themselves to be a healthy weight versus those who perceive themselves to be overweight or obese. An online survey of 396 young adults (18–25 years) evaluated background factors (participant characteristics (including perception of body weight), psychological factors, belief composites) and constructs of the Theory of Planned Behaviour (TPB) related to the adoption of genotype-based personalised advice. The association between background factors and TPB constructs was assessed using multiple linear regression. The constructs of TPB predicted intention to adopt genotype-based personalised nutrition (P < 0.001, adj. R 2 = 0.54; attitude: B = 0.24, subjective norm: B = 0.25, PBC: B = 0.45). Background factors including belief composites, health locus of control, gender, physical activity, and food choice motives of ‘health’, ‘price’, ‘familiarity’, ‘weight control’, and ‘convenience’ significantly added to models of TPB constructs related to the intention to adopt personalised advice (P < 0.05). The influence of background factors varied between TPB constructs and differed based on participants perception of their body weight. The study provides support for the use of the TPB in understanding the intention of young adults to adopt gene-based advice for dietary and physical activity behaviour. In addition to perceived body weight, the background factors identified should help to inform and modify the delivery of advice in behaviour change interventions that seek to use genotype-based personalised advice in young adult populations.


  • Open Access

    The Genetics of Sweet Taste: Perception, Feeding Behaviours, and Health

    by Harry Stevens, Francesco Piluso, Paolo Gasparini, Yiannis Mavrommatis, Leta Pilic, Catherine Anna-Marie Graham, Maria Pina Concas

    Background: Sweet taste is partly modified by genetics. The rs35874116 single-nucleotide polymorphism (SNP) in taste receptor type 1 member 2 (TAS1R2) reduces the availability of a G protein-coupled receptor (GPCR), which binds to ‘sweet’ molecules. This might alter sweet taste perception, diet choices, and health outcomes. However, these findings, and other genes and pathways involved in sweet taste are yet to be identified. Therefore, a candidate gene study on TAS1R2 and a genome-wide association study (GWAS) exploring these outcomes were performed. Methods: TAS1R2 rs35874116, sweet perception, liking, diet, and health were investigated in two age- and sex-matched European cohorts (UK, n = 50/Italy, n = 235). Linear models were used to explore associations. The GWAS was performed with 2555 Italian participants. Associations with sweet food liking, food adventurousness (FA), reward dependence (RD), and health were explored. Results: The wildtype of TAS1R2 was associated with increased sweet taste and food liking (p = 0.049, β = 0.62, p = 0.038, β = 0.45), increased fibre consumption (p = 0.006, β = 7.95), and decreased HDL cholesterol (p = 0.025, β = −3.56). The GWAS identified rs58931966 in the regulator of G-protein signalling 9 (RGS9) gene. The minor allele was associated with decreased sweet food liking (p = 7.05 × 10 – 9, β = 0.3), a higher BMI (p = 0.007, β = 0.391), serum glucose (p = 0.013, β = 1.211), lower FA (p = 0.049, β = −0.065), and RD (p = 0.011, β = −3.840). Discussion: The TAS1R2 results show that taste receptor variations are associated with preference, diet, and health-related outcomes. TAS1R2 not reaching significance in the GWAS shows that sweet food liking is modified by pathways besides taste reception. RSG9 is expressed in the striatum, which is involved in the mesolimbic reward pathway, which is activated by sweet taste. RGS9 rs58931966 may moderate dopaminergic signalling in response to sweet foods via the negative regulation of G-protein signalling. This might explain why the minor allele was associated with reduced RD. The lower FA might decrease preference for bitter-tasting vegetables, which could explain the higher BMI and serum glucose. The FA and RD results provide evidence that food choice depends on psychological/biological interplay. These results show that sweet taste is modified by multiple pathways and genes, and variations can modify taste, diet, and health outcomes.


  • A systematic review of variations in circadian rhythm genes and type 2 diabetes

    by Harry Stevens, Giulia Verdone, Leonie Lang, Catherine Graham, Leta Pilic, Yiannis Mavrommatis

    Background: Type 2 diabetes is a chronic disease that has severe individual and societal consequences, which is forecast to worsen in the future. A new field of investigation is variations in circadian rhythm genes, in conjunction with diet and sleep variables, associations with, and effects on, type 2 diabetes development. Objective: This systematic review aimed to analyse all current literature regarding circadian rhythm gene variations and type 2 diabetes, and explore their interplay with diet and sleep variables on type 2 diabetes outcomes. This review was registered with PROSPERO (CRD42021259682). Methodology: Embase and Pubmed were searched on 6/8/2021/11/8/2021 for studies of all designs, including participants from both sexes, all ethnicities, ages, and geographic locations. Participants with risk alleles/genotypes were compared with the wildtype regarding type 2 diabetes outcomes. Studies risk of bias were scored according to the risk of bias in non-randomised studies – interventions/exposures criteria. Results: In total, 31 studies were found (association n = 29/intervention n = 2) including >600,000 participants from various ethnicities, sexes, and ages. Variations in the melatonin receptor 1B, brain and muscle arnt-like 1 and period circadian regulator (PER) genes were consistently associated with type 2 diabetes outcomes. Conclusions: Individuals with variations in melatonin receptor 1B, brain and muscle arnt-like 1 and PER may be at higher risk of type 2 diabetes. Further research is needed regarding other circadian rhythm genes. More longitudinal studies and randomised trials are required before clinical recommendations can be made.